Multiple metabolic and microvascular proteins

The term Multiple metabolic and microvascular proteins refers to a heterogeneous group of proteins that collectively regulate systemic metabolism and maintain the structural and functional integrity of the microvasculature. This category includes primary therapeutic targets such as peroxisome proliferator-activated receptor alpha (PPAR-alpha) and sodium-glucose cotransporter 2 (SGLT2), as well as key signaling effectors like vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS), and protein kinase B (Akt) (Noonan et al., 2013; Mohamed et al., 2021). These proteins are central to the pathophysiology of type 2 diabetes and its microvascular complications, including retinopathy, nephropathy, and neuropathy. Dysregulation of these proteins leads to impaired glucose and lipid metabolism, increased oxidative stress, and vascular dysfunction. Therapeutic agents such as fenofibrate and SGLT2 inhibitors exert pleiotropic effects by modulating these multiple proteins, thereby providing integrated metabolic and microvascular benefits. Understanding the interplay between these multiple proteins is essential for developing comprehensive treatment strategies for cardiometabolic diseases.

Other names

Metabolic and microvascular factorsMetabolic and microvascular biomarkersPleiotropic targets of fenofibrate

Modulation of multiple pathways including PPAR-alpha activation, SGLT2 inhibition, and GLP-1 receptor agonism, leading to improved metabolic control and microvascular protection.